Atlas Trials

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

Clinical trial NCT01202747 · COMPLETED

Trial details

NCT number
NCT01202747
Sponsor
TearScience, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
ChalazionDry Eye Syndromes
Start date
2010-09-01
Primary completion
2011-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.